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Résumé en
anglais
BACKGROUND: Extra-mammary Paget's disease is a rare form of intraepithelial
adenocarcinoma with a variable pattern of invasion, sometimes associated with
distant malignancy. Vulvar Paget's disease (VPD) represents 1% of all vulvar cancers.
Standard treatment is surgical excision, however, the recurrence rate is high and
surgery leads to anatomical, functional, and sexual morbidity. Some case series
suggest efficacy of photodynamic (PDT) as treatment for this indication.
OBJECTIVES: Our aim was to assess the efficacy and tolerance of PDT in women
suffering from VPD.
MATERIALS & METHODS: A retrospective study was conducted on all patients
suffering from VPD, treated with PDT at six hospitals in France. Clinical data,
histopathological reports at diagnosis, therapeutic history, PDT schedule, tolerance,
and clinical response were reported.
RESULTS: Thirteen women were included, with a mean age of 70.1 years. Ten women
had an in situ disease, two had <1-mm dermal involvement, and one had adnexal
involvement. All PDT courses were carried out using the same light source and
photosensitizing agent. Complete response was achieved in two patients (15%) and
partial response in five patients (38%). Five patients (38%) had stable disease and one
(7%) had progressive disease. Ten of the 13 patients underwent pain evaluation; in six
cases (60%), pain was described as moderate to intense.
CONCLUSION: PDT appears to be a therapeutic option for patients with VPD, with a
response rate similar to that of other therapies usually recommended, such as surgery
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